Skip Navigation LinksHome > December 2011 - Volume 66 - Issue 12 > Antidepressants in Pregnancy: A Review of Commonly Prescribe...
Obstetrical & Gynecological Survey:
doi: 10.1097/OGX.0b013e31823e0cbf
CME Program: CME REVIEW ARTICLE 35

Antidepressants in Pregnancy: A Review of Commonly Prescribed Medications

Patil, Avinash S. MD*; Kuller, Jeffrey A. MD†; Rhee, Eleanor H. J. MD‡

Continued Medical Education
Collapse Box

Abstract

Perinatal depression is an increasingly common comorbidity of pregnancy and is associated with adverse birth outcomes. Newer classes of antidepressants have been developed with a variety of mechanisms and improved side effect profiles. There is increasing use of these medications in reproductive-aged women. Medical providers have to balance the need to prevent relapse of maternal depressive symptoms with the need to minimize fetal exposure to medications. We review the literature on 10 of the most commonly used antidepressant medications: citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, venlafaxine, duloxetine, bupropion, and mirtazapine. The pharmacokinetic properties of the medications are detailed, as well as practical considerations for their use in pregnant and lactating women. Guidance on counseling and management of pregnancies complicated by perinatal depression is discussed.

Target Audience: Obstetricians & Gynecologists and Family Physicians.

Learning Objectives: After completing this CME activity, physicians should be better able to differentiate the current classes of medications utilized commonly for perinatal depression, evaluate the reported adverse effects of antidepressant medications on the patient and developing fetus and choose the appropriate antidepressant medications for a depressed patient who is breast-feeding.

© 2011 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share